Simultaneous fatal poisoning of two victims with 4F-MDMB-BINACA and ethanol
暂无分享,去创建一个
[1] H. Neels,et al. Suicide by vaping the synthetic cannabinoid 4F-MDMB-BINACA: cannabinoid receptors and fluoride at the crossroads of toxicity? , 2021, Forensic Science, Medicine and Pathology.
[2] Y. Hurd,et al. Respiratory failure in confirmed synthetic cannabinoid overdose , 2021, Clinical toxicology.
[3] J. Lappin,et al. 'Synthetic cannabis': A dangerous misnomer. , 2021, The International journal on drug policy.
[4] R. Laprairie,et al. Assessment of select synthetic cannabinoid receptor agonist bias and selectivity between the type 1 and type 2 cannabinoid receptor , 2021, Scientific reports.
[5] N. Kalk,et al. Synthetic Cannabinoid-Related Deaths in England, 2012-2019. , 2021, Cannabis and cannabinoid research.
[6] C. Stove,et al. Synthesis and in Vitro Cannabinoid Receptor 1 Activity of Recently Detected Synthetic Cannabinoids 4F-MDMB-BICA, 5F-MPP-PICA, MMB-4en-PICA, CUMYL-CBMICA, ADB-BINACA, APP-BINACA, 4F-MDMB-BINACA, MDMB-4en-PINACA, A-CHMINACA, 5F-AB-P7AICA, 5F-MDMB-P7AICA, and 5F-AP7AICA. , 2020, ACS chemical neuroscience.
[7] E. Chan,et al. Diagnosing intake and rationalizing toxicities associated with 5F-MDMB-PINACA and 4F-MDMB-BINACA abuse , 2020, Archives of Toxicology.
[8] S. Nikas,et al. Cannabinoid-2 Agonism with AM2301 Mitigates Morphine-Induced Respiratory Depression. , 2020, Cannabis and cannabinoid research.
[9] J. Rutherford,et al. Emergence of Cumyl-PEGACLONE-related fatalities in the Northern Territory of Australia , 2020, Forensic Science, Medicine and Pathology.
[10] Oya Yeter. Simultaneous determination of 4F-MDMB BINACA, a new synthetic cannabinoid, and its metabolites in human blood samples by LC-MS/MS , 2020, Journal of the Turkish Chemical Society Section A: Chemistry.
[11] K. Tomiyama,et al. Synthetic cannabinoids enhanced ethanol-induced motor impairments through reduction of central glutamate neurotransmission. , 2020, Toxicology and applied pharmacology.
[12] K. Walsh,et al. Molecular Pharmacology of Synthetic Cannabinoids: Delineating CB1 Receptor-Mediated Cell Signaling , 2020, International journal of molecular sciences.
[13] S. Stables,et al. An outbreak of deaths associated with AMB-FUBINACA in Auckland NZ , 2020, EClinicalMedicine.
[14] C. Hess,et al. The synthetic cannabinoid 5F-MDMB-PICA: A case series. , 2020, Forensic science international.
[15] R. Giorgetti,et al. Post-Mortem Toxicology: A Systematic Review of Death Cases Involving Synthetic Cannabinoid Receptor Agonists , 2020, Frontiers in Psychiatry.
[16] J. Lappin,et al. Characteristics and circumstances of synthetic cannabinoid-related death , 2020, Clinical toxicology.
[17] S. Hillman,et al. Exploring Attachment and Internal Representations in Looked-After Children , 2020, Frontiers in Psychology.
[18] A. Dionizio,et al. Changes in energy metabolism induced by fluoride: Insights from inside the mitochondria. , 2019, Chemosphere.
[19] B. Logan,et al. 4F‐MDMB‐BINACA: A New Synthetic Cannabinoid Widely Implicated in Forensic Casework , 2019, Journal of forensic sciences.
[20] R. Gorodetsky,et al. Coma, Seizures, Atrioventricular Block, and Hypoglycemia in an ADB-FUBINACA Body-Packer. , 2018, The Journal of emergency medicine.
[21] A. Langford,et al. Synthetic cannabinoids: Variety is definitely not the spice of life. , 2018, Journal of forensic and legal medicine.
[22] W. Fantegrossi,et al. Pro-psychotic effects of synthetic cannabinoids: interactions with central dopamine, serotonin, and glutamate systems , 2018, Drug metabolism reviews.
[23] V. Angerer,et al. Three fatalities associated with the synthetic cannabinoids 5F-ADB, 5F-PB-22, and AB-CHMINACA. , 2017, Forensic science international.
[24] M. Alon,et al. Synthetic cannabinoid induced acute respiratory depression: Case series and literature review , 2017, Respiratory medicine case reports.
[25] Z. Benyó,et al. CB1 receptor-mediated respiratory depression by endocannabinoids , 2017, Respiratory Physiology & Neurobiology.
[26] R. Lam,et al. Supraventricular tachycardia and acute confusion following ingestion of e-cigarette fluid containing AB-FUBINACA and ADB-FUBINACA: a case report with quantitative analysis of serum drug concentrations , 2017, Clinical toxicology.
[27] Iain M McIntyre,et al. Synthetic cannabinoid drug use as a cause or contributory cause of death. , 2016, Forensic science international.
[28] Shane M. Wilkinson,et al. Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135. , 2015, ACS chemical neuroscience.
[29] Marilyn A Huestis,et al. Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications. , 2014, Drug and alcohol dependence.
[30] M. Troxell,et al. Acute kidney injury associated with smoking synthetic cannabinoid , 2014, Clinical toxicology.
[31] Melissa L. Langhan. Acute alcohol intoxication in adolescents: frequency of respiratory depression. , 2013, The Journal of emergency medicine.
[32] M. E. Ballard,et al. Combined effects of acute, very-low-dose ethanol and delta(9)-tetrahydrocannabinol in healthy human volunteers , 2011, Pharmacology Biochemistry and Behavior.
[33] B. Szabo,et al. Central effects of the cannabinoid receptor agonist WIN55212‐2 on respiratory and cardiovascular regulation in anaesthetised rats , 2004, British journal of pharmacology.
[34] Anthony Liguori,et al. Separate and combined effects of marijuana and alcohol on mood, equilibrium and simulated driving , 2002, Psychopharmacology.
[35] K. Usuda,et al. Usefulness of the assessment of urinary enzyme leakage in monitoring acute fluoride nephrotoxicity , 1999, Archives of Toxicology.
[36] A. Giorgetti,et al. Detection of the recently emerged synthetic cannabinoid 4F-MDMB-BINACA in 'legal high' products and human urine specimens. , 2019, Drug testing and analysis.
[37] P. Adamowicz,et al. Fatal poisoning with the synthetic cannabinoid ab-chMinaca and ethyl alcohol – a case study and literature review , 2017 .
[38] Synthetic cannabinoids in herbal products , 2011 .